UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2018 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 67

of 'Treatment of relapsed or refractory chronic lymphocytic leukemia'

67
TI
Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial
AU
Jones JA,Mato AR,Wierda WG,Davids MS,Choi M,Cheson BD,Furman RR,Lamanna N,Barr PM,Zhou L
SO
Lancet Oncol. 2017;
 
AD